
November 17, 2024
Deepen your knowledge and skills in evaluating interventions for rare diseases
Designed for professionals with a basic understanding of health technology assessment (HTA), this course provides an appreciation of the unique challenges that rare diseases pose for HTA due to limited evidence, small patient populations, and high treatment costs.
Enroll into this course to:
- Explore the challenges for conducting HTA for rare diseases and how real world evidence supports this effort.
- Review key features of rare disease policies, HTA pathways, and funding.
- Review and discuss case studies comparing the HTA experiences.
- Discuss implications for future policy and practice.
- Discuss the methodological challenges of HTA in rare disease.
This short course is offered in-person at the ISPOR Europe 2024 conference.
*Conference attendance is not required to attend an ISPOR Short Course. Separate registration is required for conference attendees.
LEVEL: Intermediate
TRACK: Health Technology Assessment
HEOR Key Competency: 9.2 Health Technology Assessment (HTA) Evidence Requirements and Development
LENGTH: 4 Hours | Course runs 1 day
FACULTY MEMBERS
Schedule:
Sunday, 17 November 2024 | Course runs 1 Day
13:00-17:00 Central European Time (CET)
Register Here
*Conference attendance is not required to attend an ISPOR Short Course. Separate registration is required for conference attendees.
Visit the ISPOR Europe 2024 Program page to view all short courses offered.